Global
Direct-to-Consumer Genetic Testing Market to Reach Worth USD 340 Mn by 2022:
Rising Awareness about Genetic Diseases to Drive the Market Growth
According to the latest report published by
Credence Research, Inc. “Direct-to-Consumer Genetic Testing: Market Growth,
Future Prospects and Competitive Analysis, 2016-2022,” the direct-to-consumer genetic testing market was
valued at USD 70.2 Mn in 2015, and is
expected to reach USD 340 Mn by 2022, expanding at a CAGR of 25.1% from 2016 to
2022.
Browse the
full report Direct-to-Consumer Genetic Testing: Market Growth, Future Prospects
and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/direct-to-consumer-genetic-testing-market
Market
Insights
Conventionally, genetic tests have been made
available only through healthcare providers at recommendations from physicians.
Direct-to-consumer (DTC) genetic testing is defined as genetic teats marketed
directly to individuals through agencies such as internet, pharmacies and
others. DTC genetic testing market is predominantly driven by growing awareness
in public about genetic diseases, growing tendency to take proactive role in
personal healthcare and the ongoing trend of understanding ancestral origins.
Since 2010, the prices of genome testing
solutions have observed a sharp decline in prices and the market is mostly
concentrated in the hands of a few market players. The utilization of genomic
data is yet not perfected, however increasing researches and growing
availability of these solutions will pave way for further improvements in the
business dynamics. On the other hand, notable risks such as vulnerability to
misleading outcomes from unproven or invalid diagnosis, taking improper
precautions or health decisions sans involvement of physician assistance and
the associated repercussions may hold back the pace of this market. Another
challenge to the market growth is potential risk of invasion of genetic privacy
through unauthorized use of consumer data.
Download
PDF Sample Report @ http://www.credenceresearch.com/sample-request/57820
Genetic data services are roughly categorized
into two sections namely, genome reading and interpretation of genomic data.
The current market players mostly offer services that club the two categories
into a single product. However some players have a differentiated their
portfolio by offering DNA genotype as an individual product. Companies offering
DTC genetic tests have varied portfolio and have varied revenue sources.
The global DTC genetic testing market is
highly concentrated, with a handful of companies offering testing solutions.
Some of the major players offering direct-to-consumer genetic testing solutions
are 23andMe, MD Revolution, GeneByGene, DNA DTC, Genetrainer, Myriad Genetics,
Genecodebook Oy and others.
About Us:
Credence Research is a worldwide market
research and counseling firm that serves driving organizations, governments,
non legislative associations, and not-for-benefits. We offer our customers some
assistance with making enduring enhancements to their execution and understand
their most imperative objectives. Over almost a century, we’ve manufactured a
firm extraordinarily prepared to this task.
Media
Contact
Name:
Chris Smith
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph:
1-800-361-8290
No comments:
Post a Comment